{"title":"DCAF13 is essential for mouse uterine function and fertility.","authors":"Qianhui Zhou, Xiaohui Li, Ningjing Wang, Liang Zhang, Enhui Jiang, Kaixuan Wang, Xingyu Yan, Cong Zhang","doi":"10.1038/s41420-025-02583-w","DOIUrl":null,"url":null,"abstract":"<p><p>The incidence of female infertility is a growing worldwide concern and a leading cause of population decline. Therefore, understanding the pathogenesis of infertility is of utmost importance. DDB1 and CUL4 Associated Factor 13 (DCAF13) is a significant component of the CRL4 E3 ubiquitin ligase complex responsible for recognizing substrates and degrading them after polyubiquitylation. DCAF13 has been implicated in oocyte and embryo development, but its role in the uterus remains elusive. To investigate its function, we generated Dcaf13 conditional knockout (cKO) mice and discovered that the uteri of cKO mice became smaller and thinner as they mature, and the embryos were unable to implant, leading to infertility. Mechanistically, we detected aberrant expression of estrogen and progesterone receptors, along with dysregulation of estrogen- and progesterone-responsive genes in the endometrium. This led to insufficient proliferation of endometrial cells in mice. RNAseq analysis revealed an overall increase in transcription of methylation-related genes, including SUV39H2, leading to higher H3K9me3 levels and consequently hindered cell proliferation in the uterus. Furthermore, DCAF13 knockdown resulted in elevated intracellular H3K9me3 levels. In conclusion, these findings suggest that DCAF13 is essential for maintaining the structure of the uterus and fertility. This study potentially contributes to the development of new strategies aimed at improving female reproductive health.</p>","PeriodicalId":9735,"journal":{"name":"Cell Death Discovery","volume":"11 1","pages":"359"},"PeriodicalIF":7.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12316921/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Death Discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41420-025-02583-w","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The incidence of female infertility is a growing worldwide concern and a leading cause of population decline. Therefore, understanding the pathogenesis of infertility is of utmost importance. DDB1 and CUL4 Associated Factor 13 (DCAF13) is a significant component of the CRL4 E3 ubiquitin ligase complex responsible for recognizing substrates and degrading them after polyubiquitylation. DCAF13 has been implicated in oocyte and embryo development, but its role in the uterus remains elusive. To investigate its function, we generated Dcaf13 conditional knockout (cKO) mice and discovered that the uteri of cKO mice became smaller and thinner as they mature, and the embryos were unable to implant, leading to infertility. Mechanistically, we detected aberrant expression of estrogen and progesterone receptors, along with dysregulation of estrogen- and progesterone-responsive genes in the endometrium. This led to insufficient proliferation of endometrial cells in mice. RNAseq analysis revealed an overall increase in transcription of methylation-related genes, including SUV39H2, leading to higher H3K9me3 levels and consequently hindered cell proliferation in the uterus. Furthermore, DCAF13 knockdown resulted in elevated intracellular H3K9me3 levels. In conclusion, these findings suggest that DCAF13 is essential for maintaining the structure of the uterus and fertility. This study potentially contributes to the development of new strategies aimed at improving female reproductive health.
期刊介绍:
Cell Death Discovery is a multidisciplinary, international, online-only, open access journal, dedicated to publishing research at the intersection of medicine with biochemistry, pharmacology, immunology, cell biology and cell death, provided it is scientifically sound. The unrestricted access to research findings in Cell Death Discovery will foster a dynamic and highly productive dialogue between basic scientists and clinicians, as well as researchers in industry with a focus on cancer, neurobiology and inflammation research. As an official journal of the Cell Death Differentiation Association (ADMC), Cell Death Discovery will build upon the success of Cell Death & Differentiation and Cell Death & Disease in publishing important peer-reviewed original research, timely reviews and editorial commentary.
Cell Death Discovery is committed to increasing the reproducibility of research. To this end, in conjunction with its sister journals Cell Death & Differentiation and Cell Death & Disease, Cell Death Discovery provides a unique forum for scientists as well as clinicians and members of the pharmaceutical and biotechnical industry. It is committed to the rapid publication of high quality original papers that relate to these subjects, together with topical, usually solicited, reviews, editorial correspondence and occasional commentaries on controversial and scientifically informative issues.